"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...
The Federal Trade Commission has published a report that found pharmacy benefit managers Caremark Rx LLC (CVS), Express Scripts and OptumRx marked up numerous specialty generic drugs by ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
by Ishai Menache, Jeevan Pathuri, David Simchi-Levi and Tom Linton Companies face a variety of complex challenges in designing and optimizing their supply chains. Increasing their resilience ...
Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...
It's important for the new administration to understand that controlling inflation requires more than Federal Reserve action. It demands fiscal discipline.